| BACKG ROU N D
Until the onset of the 2009 influenza A/H1N1 pandemic, body mass index (BMI) was not widely appreciated as an independent risk factor for influenza. While there was no increase in the rates of ILI being reported in obese patients, 1 early reports during the pandemic noted an association between severity of illness and obesity. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] Several studies in adults found an association between obesity and death due to pandemic influenza. [11] [12] [13] [14] Another study, however, found no association between obesity and mortality in intensive care unit (ICU) participants.
15
Far fewer studies examined syndromic influenza-like illness (rather than restricted to influenza). Two studies found a link between obesity and hospitalization from influenza-like illness, 16, 17 and another showed higher rates of outpatient visits for influenza-like illness in obese patients. 18 One additional study evaluated rates of obesity in the community and demonstrated that communities with a greater prevalence of obesity were more likely to have high influenza-related hospitalization rates. 19 None of these studies, however, determined the etiology of the participants illness, and none examined low body mass index as a risk factor.
Given the limited data with syndromic ILI severity and obesity, we examined the association between body mass and severity of influenza-like illness (ILI) during four consecutive years (2010) (2011) (2012) (2013) (2014) in both pediatric and adult populations. We hypothesized that those individuals categorized as overweight, obese, and morbidly obese would be more likely to be hospitalized with ILI from influenza, but also from other respiratory viruses, as compared to those participants with a normal body mass.
| ME THODS

| Study design and sites
Beginning in April 2010, participants were enrolled in ILI 002, an observational cohort study conducted by the Mexican Emerging
Infectious Disease Clinical Research Network, Mexico (La Red). The study was conducted at five centers in Mexico City, Mexico, and one in San Luis Potosí, Mexico. The study sites are located in urban environments and include two general hospitals, two tertiary care hospitals (one that serves those with respiratory problems and one that serves those with metabolic disorders), and two tertiary care pediatric centers.
| Case definition and study population
The study population included participants of any age who presented with an influenza-like illness (ILI). Influenza-like illness was defined by the presence of at least one respiratory symptom (eg, shortness of breath, cough) and either fever (≥38°C or subjective feverishness) or one or more non-respiratory symptoms (eg, malaise, headache). The participants included were those who sought medical attention at a study center and agreed to participate in the study. 
| Study procedures
| Virology
Nasopharyngeal swab and nasal aspirate samples were sent to a cen- The outcome measure of severity of disease was defined as having severe disease if participants were hospitalized within 14 days of enrollment. Participants that were in the emergency room >24 hours yet never admitted were excluded as these cannot be clearly categorized as outpatients or hospitalized.
| Statistical analyses
All analyses were performed separately for pediatric and adult participants. Descriptive statistics include presentation of proportion for categorical variables and means and standard deviations for continuous variables. Logistic regression models were used to examine the relationship between severity of illness and BMI. Sex, chronic medical condition (present/absent), and age (as a linear term) were included in all models to adjust for imbalances.
Interactions between BMI and other covariates (adjustment variables and pathogen categories) were examined. When interaction terms were significant, logistic regression analyses were performed for each level of the covariate. We calculated the odds ratio (OR) of being hospitalized based on body mass category, where normal was the reference category. We estimated 95% confidence intervals (95% CI) and P-values of the odds ratios using the Firth method to account for separation that may occur in logistic regression models due to small sample sizes. 23 SAS version 9 (SAS Institute Inc., Cary, NC, USA) and R 3.1.0 (R Foundation for Statistical Computing, Vienna, Austria) were used to complete all analysis.
| Regulatory aspects
The 
| RE SULTS
Between In order, the five most common chronic medical conditions in adults were as follows: cardiovascular disorder, asthma, diabetes mellitus, HIV infection, and COPD. In pediatric participants, they were congenital malformation/congenital syndrome, asthma, cardiovascular disorder, chronic pulmonary diseases, and immunodeficiencies.
In order to determine whether body mass was correlated with severity of disease in these participants, we ran a multiple logistic regression analysis, controlling for age, sex, and presence of comorbid conditions, comparing each body mass category with normal serving as the baseline. We also included a viral pathogen grouping variable and interaction terms between BMI and viral pathogen group. The interaction terms allowed us to determine whether there were different effects in BMI for the different pathogen groups. This model showed that, in adults, the relationship between BMI and severity was significantly different for the influenza cohort (P < 0.0001) when compared to the virus-negative cohort, while the relationship between BMI and severity was not significantly different in the virus-negative and NIRV cohort. Therefore, separate logistic regression analyses were performed for the influenza cohort while the participants in the virus-negative and NIRV cohorts were analyzed together in one larger group. In both groups, underweight and morbidly obese participants had more severe disease than normalweight participants. In both of those body mass categories, the effect was larger in the influenza-positive group compared with the combined NIRV and virus-negative group. Underweight adult participants with influenza were 5.2 (P < 0.005) times more likely to develop severe ILI, while their influenza-negative counterparts had an OR of 2.88 (P < 0.001) ( Table 2 ). In morbidly obese adults, these numbers were 18.4 (P < 0.001) and 1.89 (P < 0.001), respectively.
While obese adults without influenza were not statistically more likely to develop severe ILI compared to normal, obese adults who were positive for influenza had an OR of 3.18 (P < 0.001).
Because and B participants (OR: 5.58, P < 0.001, Table 3 ). For participants with influenza H1N1, the risk is very strong in obese (OR: 8.96, P < 0.001) and morbidly obese (OR: 35.13, P < 0.001) participants.
There was also a small increase in risk of overweight influenza H1N1 participants (OR: 2.43, P = 0.048) compared with their normal BMI counterparts.
Similarly, the NIRV category was composed of different viruses and it was of interest to determine whether the BMI severity relationship was different among the most common respiratory viral pathogens present in the study. The five most common respiratory viruses were coronavirus, metapneumovirus, PIV, RSV, and rhinovirus/enterovirus. The same multiple logistic regression analysis was
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TA B L E 2
Odds ratio for hospitalization in participants with influenza vs other causes of ILI, based on body mass category performed as previously described. In this analysis, only participants with a single virus were included. The interaction analysis indicated a significantly (P < 0.0054) different effect for the relationship between BMI and severity in the RSV group with the BMI/severity effect being similar among the other viruses. Therefore, a separate analysis was performed for the RSV group, while the participants with other viruses were combined for the analysis. In the combined group, underweight and morbidly obese participants were at higher risk of severe disease than normal-weight participants. For the RSV participants, only obese participants (OR: 6.33, P = 0.019) were at higher risk than normal participants. (Table 3) In pediatric participants, there were no significant interactions between BMI and the pathogen groups; therefore, all of the participants were analyzed together. Only obese pediatric participants were statistically significantly more likely to develop severe ILI compared to their counterparts with a normal z-score (OR: 2.2, P = 0.002; Table 4 ).
| D ISCUSS I ON
We have demonstrated that adults that are underweight or morbidly obese are more likely to be hospitalized from an influenzalike illness, regardless of the causative agent of the illness, than normal-weight adults. The risk follows a "U"-shaped curve, where individuals at both extremes (ie, those that are underweight or morbidly obese) were more likely to develop severe ILI when compared with normal-weight, overweight, or obese individuals. The increased risk of underweight and morbidly obese adults was stronger for influenza-positive adults compared with those positive for other respiratory viruses or negative for any respiratory viruses.
Analysis of the risk of specific respiratory viral pathogens or strains of influenza was difficult given the small number of participants in each of these groups. Despite the large confidence intervals, the data seem to indicate that the association between morbid obesity and risk of severe ILI is not just statistically significant in adults with influenza A/H1N1 pdm 2009. A statistically significant OR was also found in participants with influenza H3N2 and B. While the association was also present for these strains of influenza, the odds ratio was six times higher in influenza H1N1 participants (OR:
35.13 vs 5.58), which may explain why individuals with H1N1 were the first in which the association between body mass and disease severity was postulated. However, influenza H3N2 and influenza B still have twice the risk of hospitalization as the other most common respiratory viruses. Preclinical data suggest reduced vaccine efficacy in obesity, 24, 25 and while the increased risk does not seem to be due to reduced antibody titers, 26, 27 it may be from reduced cellular immunity. 28 However, this would not explain the differential risk of H1N1 over H3N2, nor of all influenza over other respiratory viruses.
The risk associated with low body mass is a finding that has previously been described as it relates to all-cause mortality, 29, 30 but not to the severity of influenza-like illness. Being underweight seems to be a consistent risk factor in all adult participants with ILI.
Our analysis did not demonstrate a clear association between body mass and the risk of severe ILI in children. A few prior studies found obesity to be a risk factor. 31, 32 Recent studies suggest BMI zscores, as used for pediatric participants in this study, are only weakly associated with true adiposity. not reflect the appropriate categories relevant to categorizing immune dysfunction from obesity.
One significant limitation to our study is that it enrolled participants that sought medical care for an influenza-like illness. It is not a population-based study that can accurately assess the risk that body mass confers for infection. Additionally, the study cannot differentiate within the NIRV group between those with true infections (but not detected on the multiplex platform), or those with non-infectious etiologies of the respiratory symptoms.
In conclusion, our findings suggest that adults, who are underweight or morbidly obese, even if they do not have chronic conditions that increase the risk of influenza-related complications, may be at increased risk of developing severe disease due to seasonal influenza infection as well as other respiratory viral infections.
Clinicians should keep a patient's body mass index in mind when evaluating risk and deciding on a course of treatment.
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